AMG-420 multiple myeloma - Google News

Updated Data Unveiled With Emerging Treatments in Myeloma - OncLive

over 6 years ago

BMS, bluebird myeloma CAR-T on way to approval, but others closing in at ASH - MedCity News

almost 7 years ago

Kyprolis-Plus-Darzalex Boosts Amgen's Myeloma Pipeline, After MCL-1 Drugs' Clinical Holds - Scrip

about 7 years ago

B Cell Maturation Antigen BCMA Targeted Therapy Take Center in Multiple Myeloma - BioSpace

over 4 years ago

B Cell Maturation Antigen BCMA Targeted Therapy Take Center in Multiple Myeloma...

GSK gets expedited FDA review for multiple myeloma drug - medcitynews.com

over 6 years ago

Abbvie comes to the multiple myeloma party late - Vantage

over 7 years ago

ASH18: Amgen's anti-BCMA bispecific shines again, but CAR-T threat remains - FierceBiotech

almost 8 years ago

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market Report 2021-2026: Competitor Landscape, Opportunity Assessment, Approved Drugs, Drugs Patent, Price and Sales insights - PRNewswire

almost 5 years ago

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market Report 2021-2026: Competitor...

Competition intensifies in BCMA space with new approval for BMS - The Pharma Letter

over 4 years ago

Competition intensifies in BCMA space with new approval for BMS  The Pharma...

Boehringer grants rights to immuno-oncology drug for myeloma to Amgen - thepharmaletter.com

about 10 years ago

The world’s first multiple myeloma cell therapy has it all to do - evaluate.com

over 5 years ago

The world’s first multiple myeloma cell therapy has it all to do...

Amgen's BCMA drug on course to challenge CAR-Ts in myeloma - PMLiVE

almost 8 years ago